Cargando…
Medical management of lung cancer: Experience in China
Lung cancer is the leading cause of death from cancer worldwide, as well as in China. A multidisciplinary treatment strategy for lung cancer, which includes medical and radiation oncology, surgery, and pathology is used in clinical practice in China. Chinese lung cancer patients are treated accordin...
Autores principales: | Shi, Yuankai, Sun, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448475/ https://www.ncbi.nlm.nih.gov/pubmed/26273329 http://dx.doi.org/10.1111/1759-7714.12168 |
Ejemplares similares
-
Clinical experiences with molecular targeted therapy in lung cancer in China
por: Wang, Yan, et al.
Publicado: (2015) -
Current small cell lung cancer treatment in China
por: Shi, Yuankai, et al.
Publicado: (2015) -
Epidemiology of lung cancer in China
por: Cao, Maomao, et al.
Publicado: (2018) -
Early detection of lung cancer: Low-dose computed tomography screening in China
por: Zhao, Shi-Jun, et al.
Publicado: (2015) -
Role of circulating tumor DNA in the management of early‐stage lung cancer
por: Zhao, Heng, et al.
Publicado: (2018)